Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Global X MLP & Energy Infrastructure ETF
MLPX
$3.61B
| $225K | ﹤0.01% |
5,900
-18,200
| -76% | -$767K |
|
3602
Tennant Co
TNC
$1.43B
| $225K | ﹤0.01% |
+3,800
| New | +$245K |
|
|
YI
3603
111 Inc
YI
$33.9M
| $225K | ﹤0.01% |
10,905
+7,610
| +231% | +$152K |
|
3604
Bank7 Corp
BSVN
$479M
| $224K | ﹤0.01% |
9,800
-12,093
| -55% | -$284K |
|
|
NXXT
3605
NextNRG Inc
NXXT
$45.6M
| $224K | ﹤0.01% |
13,995
-1,270
| -8% | -$16.4K |
|
3606
Escalade
ESCA
$273M
| $223K | ﹤0.01% |
17,130
-31,500
| -65% | -$412K |
|
|
SILV
3607
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $223K | ﹤0.01% |
+36,500
| New | +$277K |
|
|
YQ
3608
17 Education & Technology Group
YQ
$18.7M
| $222K | ﹤0.01% |
22,571
+5,316
| +31% | +$55.5K |
|
|
BEDU
3609
DELISTED
Bright Scholar Education Holdings
BEDU
| $221K | ﹤0.01% |
75,575
-8,850
| -10% | -$24.4K |
|
3610
Sonoma Pharmaceuticals
SNOA
$5.26M
| $221K | ﹤0.01% |
3,788
+770
| +26% | +$49.3K |
|
3611
Xilio Therapeutics
XLO
$59.9M
| $220K | ﹤0.01% |
+5,379
| New | +$285K |
|
|
ACHL
3612
DELISTED
Achilles Therapeutics
ACHL
| $220K | ﹤0.01% |
87,233
+56,700
| +186% | +$140K |
|
3613
Amalgamated Financial
AMAL
$1.48B
| $218K | ﹤0.01% |
+11,000
| New | +$212K |
|
3614
Invesco China Technology ETF
CQQQ
$3.03B
| $217K | ﹤0.01% |
+4,300
| New | +$194K |
|
3615
Sharplink Inc
SBET
$1.29B
| $217K | ﹤0.01% |
2,022
-328
| -14% | -$40K |
|
3616
American Superconductor
AMSC
$1.42B
| $216K | ﹤0.01% |
41,689
-38,200
| -48% | -$221K |
|
3617
Outlook Therapeutics
OTLK
$183M
| $216K | ﹤0.01% |
10,570
-25,890
| -71% | -$744K |
|
3618
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.71B
| $214K | ﹤0.01% |
+2,800
| New | +$234K |
|
3619
Exicure
XCUR
$10.2M
| $214K | ﹤0.01% |
19,779
+10,649
| +117% | +$224K |
|
|
FNHC
3620
DELISTED
FedNat Holding Company Common Stock
FNHC
| $214K | ﹤0.01% |
691,670
+103,209
| +18% | +$56.4K |
|
|
FRSX
3621
Foresight Autonomous Holdings
FRSX
$3.9M
| $213K | ﹤0.01% |
2,728
-84
| -3% | -$8.28K |
|
3622
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
| $212K | ﹤0.01% |
+9,541
| New | +$231K |
|
3623
Silicom
SILC
$229M
| $212K | ﹤0.01% |
6,300
-34,300
| -84% | -$1.22M |
|
3624
Mistras Group
MG
$484M
| $211K | ﹤0.01% |
35,600
-30,700
| -46% | -$182K |
|
3625
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $211K | ﹤0.01% |
4,700
-2,400
| -34% | -$120K |
|
Similar funds
Renaissance Technologies's Q2 2022 Portfolio in Review
As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
- Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
- Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
- Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.